LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Canertinib | 1.11 | uM | LJP6 | 72 | hr | 1334 | 3479 | 3970 | 0.8763 | 0.8137 |
| BT-20 | Celastrol | 1.11 | uM | LJP6 | 72 | hr | 1334 | 3231 | 3970 | 0.8138 | 0.7195 |
| BT-20 | CGP60474 | 1.11 | uM | LJP5 | 72 | hr | 1334 | 439 | 3970 | 0.1106 | -0.3398 |
| BT-20 | CGP60474 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 397 | 3970 | 0.1001 | -0.3556 |
| BT-20 | CHIR-99021 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 4191 | 3970 | 1.0555 | 1.0836 |
| BT-20 | CP724714 | 1.11 | uM | LJP5 | 72 | hr | 1334 | 3536 | 3970 | 0.8905 | 0.8350 |
| BT-20 | CP466722 | 1.11 | uM | LJP5 | 72 | hr | 1334 | 4106 | 3970 | 1.0342 | 1.0515 |
| BT-20 | Crizotinib | 1.11 | uM | LJP5 | 72 | hr | 1334 | 3151 | 3970 | 0.7936 | 0.6891 |
| BT-20 | Momelotinib | 1.11 | uM | LJP5 | 72 | hr | 1334 | 3375 | 3970 | 0.8500 | 0.7741 |
| BT-20 | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 1334 | 1468 | 3970 | 0.3698 | 0.0507 |
| BT-20 | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 1334 | 1333 | 3970 | 0.3357 | -0.0006 |
| BT-20 | Dovitinib | 1.11 | uM | LJP5 | 72 | hr | 1334 | 2102 | 3970 | 0.5294 | 0.2912 |
| BT-20 | Enzastaurin | 1.11 | uM | LJP5 | 72 | hr | 1334 | 4113 | 3970 | 1.0359 | 1.0540 |
| BT-20 | Erlotinib | 1.11 | uM | LJP5 | 72 | hr | 1334 | 3554 | 3970 | 0.8950 | 0.8419 |
| BT-20 | Foretinib | 1.11 | uM | LJP5 | 72 | hr | 1334 | 1031 | 3970 | 0.2598 | -0.1149 |
| BT-20 | R406 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 3852 | 3970 | 0.9701 | 0.9549 |
| BT-20 | Pictilisib | 1.11 | uM | LJP6 | 72 | hr | 1334 | 2431 | 3970 | 0.6124 | 0.4161 |
| BT-20 | Gefitinib | 1.11 | uM | LJP6 | 72 | hr | 1334 | 3848 | 3970 | 0.9691 | 0.9535 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP5 | 72 | hr | 1334 | 976 | 3970 | 0.2458 | -0.1361 |
| BT-20 | Geldanamycin | 1.11 | uM | LJP6 | 72 | hr | 1334 | 968 | 3970 | 0.2439 | -0.1390 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP5 | 72 | hr | 1334 | 774 | 3970 | 0.1951 | -0.2124 |
| BT-20 | GSK1059615 | 1.11 | uM | LJP6 | 72 | hr | 1334 | 784 | 3970 | 0.1976 | -0.2086 |
| BT-20 | GSK1904529A | 1.11 | uM | LJP6 | 72 | hr | 1334 | 3796 | 3970 | 0.9560 | 0.9338 |
| BT-20 | Omipalisib | 1.11 | uM | LJP6 | 72 | hr | 1334 | 734 | 3970 | 0.1849 | -0.2277 |
| BT-20 | GSK 690693 | 1.11 | uM | LJP5 | 72 | hr | 1334 | 2757 | 3970 | 0.6944 | 0.5397 |